IMPACT BIOMEDICAL INC. - 8-K Filing

Impact Biomedical Inc. announces SEC effectiveness of Form F-4 registration statement for proposed merger with Zoar Limited. (Items: 7.01 Regulation FD Disclosure On November 2, 2026, the Company released a press release relating to the effectiveness of its Form F-4 registration, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $IBO

Read the full article at SEC EDGAR

More Regulatory news